NO20072478L - Salter av isofosforamidsennep og analoger av disse som antitumor midler - Google Patents

Salter av isofosforamidsennep og analoger av disse som antitumor midler

Info

Publication number
NO20072478L
NO20072478L NO20072478A NO20072478A NO20072478L NO 20072478 L NO20072478 L NO 20072478L NO 20072478 A NO20072478 A NO 20072478A NO 20072478 A NO20072478 A NO 20072478A NO 20072478 L NO20072478 L NO 20072478L
Authority
NO
Norway
Prior art keywords
salts
isophosphoramide mustard
analogues
methods
antitumor agents
Prior art date
Application number
NO20072478A
Other languages
English (en)
Norwegian (no)
Inventor
Lee Morgan
Original Assignee
Dekk Tec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dekk Tec Inc filed Critical Dekk Tec Inc
Publication of NO20072478L publication Critical patent/NO20072478L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/222—Amides of phosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20072478A 2004-10-25 2007-05-16 Salter av isofosforamidsennep og analoger av disse som antitumor midler NO20072478L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62208704P 2004-10-25 2004-10-25
US67270705P 2005-04-18 2005-04-18
PCT/US2005/038523 WO2006047575A2 (en) 2004-10-25 2005-10-25 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Publications (1)

Publication Number Publication Date
NO20072478L true NO20072478L (no) 2007-06-25

Family

ID=35788704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072478A NO20072478L (no) 2004-10-25 2007-05-16 Salter av isofosforamidsennep og analoger av disse som antitumor midler

Country Status (17)

Country Link
US (4) US8232262B2 (cg-RX-API-DMAC7.html)
EP (3) EP1805192B1 (cg-RX-API-DMAC7.html)
JP (1) JP5336082B2 (cg-RX-API-DMAC7.html)
KR (2) KR20130041384A (cg-RX-API-DMAC7.html)
CN (3) CN101087800B (cg-RX-API-DMAC7.html)
AU (1) AU2005299385B2 (cg-RX-API-DMAC7.html)
CA (1) CA2585125C (cg-RX-API-DMAC7.html)
DK (2) DK2336140T3 (cg-RX-API-DMAC7.html)
ES (2) ES2565929T3 (cg-RX-API-DMAC7.html)
HK (1) HK1209752A1 (cg-RX-API-DMAC7.html)
IL (3) IL182752A (cg-RX-API-DMAC7.html)
NO (1) NO20072478L (cg-RX-API-DMAC7.html)
NZ (2) NZ589418A (cg-RX-API-DMAC7.html)
PL (1) PL1805192T3 (cg-RX-API-DMAC7.html)
PT (1) PT1805192E (cg-RX-API-DMAC7.html)
SI (1) SI1805192T1 (cg-RX-API-DMAC7.html)
WO (1) WO2006047575A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2585125C (en) 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US7964583B2 (en) 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) * 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체
SG183657A1 (en) * 2008-07-31 2012-09-27 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
WO2010099213A1 (en) 2009-02-24 2010-09-02 Dekk-Tec, Inc. Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
CN102659841B (zh) * 2012-04-24 2015-03-25 石家庄学院 多元酚磷酰胺衍生物及其制备方法与应用
US10172789B2 (en) 2013-01-24 2019-01-08 Palvella Therapeutics Llc Compositions for transdermal delivery of mTOR inhibitors
CN108348780A (zh) * 2015-09-10 2018-07-31 贝克顿·迪金森公司 用作用于环磷酰胺和异环磷酰胺的免疫分析的免疫原和分析缀合物的环磷酰胺类似物
WO2018129364A1 (en) 2017-01-06 2018-07-12 Palvella Therapeutics Llc Anhydrous compositions of mtor inhibitors and methods of use
EP3684944B1 (en) 2017-09-21 2025-01-01 Becton, Dickinson and Company Hazardous contaminant collection kit and rapid testing
CN111107939B (zh) 2017-09-21 2022-04-12 贝克顿·迪金森公司 引导有害污染物样品的收集的系统和模板及使用其的方法
USD859683S1 (en) 2017-09-21 2019-09-10 Becton, Dickinson And Company Collection device
JP7223749B2 (ja) 2017-09-21 2023-02-16 ベクトン・ディキンソン・アンド・カンパニー 危険汚染物質の試験における高ダイナミックレンジの分析器
EP3817743A4 (en) 2018-07-02 2022-07-06 Palvella Therapeutics, Inc. ANHYDROUS COMPOSITIONS OF MTOR INHIBITORS AND METHODS OF USE
WO2020068657A1 (en) * 2018-09-25 2020-04-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
CN113383222A (zh) 2019-01-28 2021-09-10 贝克顿·迪金森公司 具有集成的拭子和测试装置的有害污染物收集装置
CN111973583A (zh) * 2020-07-29 2020-11-24 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 芹菜素在制备促进缺血超长随意皮瓣存活药物的作用
CN111943979B (zh) 2020-10-19 2020-12-22 南京卓康医药科技有限公司 一种异环磷酰胺中间体及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU427945A1 (ru) 1972-07-24 1974-05-15 Институт элементоорганических соединений СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ
JPS5159886A (cg-RX-API-DMAC7.html) 1974-11-20 1976-05-25 Shionogi Seiyaku Kk
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
PL264222A1 (en) * 1986-02-22 1988-04-14 Method of obtaining novel heterocyclic compounds with 2-(2-/n,n-bis-(2-chloroethyl)-diamido-phosphoryloxy/ethyl)group
US4841085A (en) * 1986-06-30 1989-06-20 Board Of Regents, University Of Texas System Aldophosphamides
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
WO1993021173A1 (en) 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5468499A (en) * 1993-11-15 1995-11-21 Ohio State University Liposomes containing the salt of phosphoramide mustard and related compounds
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
JP4629238B2 (ja) * 1999-05-24 2011-02-09 サザン・リサーチ・インスティテュート イソホスホアミドマスタード・アナログ及びその使用
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
AU2001248201B2 (en) 2000-04-13 2006-12-14 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
DE10064312C2 (de) * 2000-12-22 2003-05-22 Degussa Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
CA2585125C (en) * 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체
SG183657A1 (en) * 2008-07-31 2012-09-27 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof

Also Published As

Publication number Publication date
EP1805192A2 (en) 2007-07-11
CN101087800A (zh) 2007-12-12
EP2336140A2 (en) 2011-06-22
DK2336140T3 (en) 2016-03-21
IL182752A0 (en) 2007-07-24
US8795659B2 (en) 2014-08-05
EP2336139A3 (en) 2012-01-04
NZ555323A (en) 2010-12-24
PT1805192E (pt) 2013-01-23
AU2005299385A1 (en) 2006-05-04
US8232262B2 (en) 2012-07-31
HK1100945A1 (en) 2007-11-16
WO2006047575A2 (en) 2006-05-04
US9346836B2 (en) 2016-05-24
ES2397165T3 (es) 2013-03-05
SI1805192T1 (sl) 2013-02-28
US20150152125A1 (en) 2015-06-04
KR20130041384A (ko) 2013-04-24
EP2336139A2 (en) 2011-06-22
PL1805192T3 (pl) 2013-03-29
EP1805192B1 (en) 2012-10-17
EP2336140B1 (en) 2016-01-27
NZ589418A (en) 2012-03-30
US7678778B2 (en) 2010-03-16
AU2005299385B2 (en) 2011-06-16
WO2006047575A3 (en) 2006-08-10
US20080267945A1 (en) 2008-10-30
KR101292026B1 (ko) 2013-08-01
CN101087800B (zh) 2015-01-07
HK1209752A1 (en) 2016-04-08
IL211936A (en) 2012-12-31
EP2336140A3 (en) 2012-01-11
JP2008517949A (ja) 2008-05-29
IL211935A0 (en) 2011-05-31
JP5336082B2 (ja) 2013-11-06
US20130149296A1 (en) 2013-06-13
IL182752A (en) 2012-09-24
CN103172662A (zh) 2013-06-26
CN104558023A (zh) 2015-04-29
IL211936A0 (en) 2011-05-31
CA2585125C (en) 2014-04-22
CA2585125A1 (en) 2006-05-04
DK1805192T3 (da) 2013-02-04
US20060089333A1 (en) 2006-04-27
KR20070121632A (ko) 2007-12-27
ES2565929T3 (es) 2016-04-07

Similar Documents

Publication Publication Date Title
WO2006047575A3 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
EA200970171A1 (ru) Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
NO20085060L (no) Triazolpyrazinderivater anvendelige som anti-cancermidler
CY1112831T1 (el) Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh
MY150289A (en) Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof
AP2001002358A0 (en) Salt forms of 3-(4-bromo-2,6-difluoro-benzyloxy)-5-[3-(4- pyrrolidin-1-yl-butyl)ureido]-isothiazole-4-carboxilic acid amide and method of production.
MX2010001005A (es) Derivados de (hetero)aril-metilen-n-cicloalquilcarboxamida condensados de 6 elementos con n como fungicidas.
EP2423207A3 (en) 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors
BR0313160A (pt) Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
WO2008093024A3 (fr) Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2-carboxamides, leur préparation et leur application en therapeutique
CY1108529T1 (el) Νεα αζαδικυκλικα παραγωγα, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τα περιεχουν
DE602004019814D1 (de) Imidazolderivate, verfahren zu deren herstellung und deren anwendungen
DK1476470T3 (da) Stivelsesderivater, stivelse-aktivstof-konjugater, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemidler
WO2007119001A3 (fr) Derives d 'aminomethyl pyridine, leur preparation et leur application en therapeutique
EA200702375A1 (ru) Производные мочевины, способы их получения и применения
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
NO20073549L (no) Fremgangsmate for fremstilling av organiske forbindelser
CY1110622T1 (el) Νεα παραγωγα 3-φαινυλοπροπιονικου οξεος για την αντιμετωπιση του διαβητη
NO20063859L (no) Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter
NZ504298A (en) 2,3-methano-amino acid compounds for treating serine protease disorders
TW200719889A (en) Amino acid derivatives
SG165381A1 (en) Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors
DE502004006253D1 (de) Substituierte benzoylureidopyridyl-piperidin- und -pyrrolidin-carbons urederivate, verfahren zu deren herstellung und deren v erwendung
CY1113675T1 (el) Αλατα μουσταρδας ισοφωσφοραμιδιου και αναλογα αυτων ως αντικαρκινικοι παραγοντες
ZA200706705B (en) Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application